Loading stock data…
CHF 368.10+8.40 (+2.33%)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
Roche Holding AG in the Healthcare sector is trading at $368.10 with a market capitalization of $285.8B. Wall Street consensus targets $377.24 (19 analysts), implying a +2.5% move over the next 12 months. The stock is currently near its 52-week high of $375.80, remaining 8.9% above its 200-day moving average. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (CHF) · Annual | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total Revenue | CHF 65.81B↑ | CHF 60.44B↓ | CHF 62.40B↓ | CHF 63.36B |
| Gross Profit | CHF 46.08B↑ | CHF 44.08B↓ | CHF 46.11B↓ | CHF 46.71B |
| Operating Income | CHF 17.48B↑ | CHF 15.39B↑ | CHF 13.42B↓ | CHF 18.48B |
| Net Income | CHF 12.42B↑ | CHF 11.50B↑ | CHF 8.28B↓ | CHF 12.88B |
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tum...